References
- Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature 1971;231:232 —5.
- Vane JR, Botting RM. Mechanism of action of aspirin-like drugs. Semin Arthritis Rheum 1997;26 Supp. 1: 2–10.
- Jouzeau JY, Terlain B, Abid A, Nedelac E, Netter P. Cyclo-oxygenase isoenzymes. Drugs 1997;53:563 — 82.
- Needleman P, Isakson PC. The discovery and function of COX-2. J Rheumatol 1997;24 Supp. 49: 6 — 8.
- Needleman P, Isakson PC. The discovery and function of COX-2. The Journal of Rheumatology 1997;24 Supp. 49: 6 — 7.
- Smith WL, DeWitt DL. Biochemistry of prostaglandin endo-peroxide H synthase-1 and synthase-2 and their differential susceptibility to non-steroidal anti-inflammatory drugs. Semin Nephrol 1995;15:179–94.
- Kurumbail RG, Stevens AM, Gierse JK, et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflamma-tory agents. Nature 1996;384 (6610):644 — 8.
- Bloom BS. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med 1988;84 Supp. 2A:20 —4.
- Patrignani P, Panara MR, Sciulli MG, Santini G, Renda G, Patrono C. Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflam-matory drugs. J Physiol Pharmacol 1997;48:623 —31.
- Harris RC. The macula densa: recent developments. J Hyper-tens 1996;14:815 — 22.
- Siegle I, Klein T, Backman JT, Saal JG, Nusing RM, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 1998;4:122 —9.
- Amin AR, Attur M, Patel RN, et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected car-tilage, influence of nitric oxide. J Clin Invest 1997;99:1231 —7.
- Siegle I, Klein T, Backman JT, Saal JG, Nusing R, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 1998;41:122 — 9.
- Stewart WF, Kawas C, Carrada M, Metter EJ. Risk of Alzhei-mer's disease and duration of NSAID use. Neurology 1997;48:626— 32.
- Reddy BS, Rao CV and Selbert K. Evaluation of cyclooxygen-ase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 1996;56: 4566 —69.
- Peleg II, Maibach HT, Brown SH, Wilcox CM. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of sub-sequent colorectal cancer. Arch Intern Med 1994;154:394 — 9.